주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Pharma
목록
(
총 :
2,298 )
기사목록 보기 형태
제목형
요약형
포토형
Regulator grants conditional approval to Astellas’ leukemia therapy Xospata
Shim Hyun-tai
2021.09.03 17:36
‘Alunbrig is the 1st choice among ALK first-line therapies'
Lee Han-soo
2021.09.03 17:36
Acute myeloid leukemia drug Xospata nears getting insurance benefits
Kim Eun-young
2021.09.03 15:23
Samyang Biopharm USA speeds up cancer immunotherapy through global collaborations
Shim Hyun-tai
2021.09.02 16:39
HLB to present results of rivoceranib at global lung cancer meeting
Shim Hyun-tai
2021.09.02 12:29
Hanall Biopharma’s Chinese partner to conduct study of autoimmune disorder drug
Shim Hyun-tai
2021.09.02 11:57
Voronoi licenses out autoimmune disease treatment to Brickell Biotech
Lee Han-soo
2021.09.02 11:57
Pfizer’s acromegaly treatment receives reimbursement
Lee Han-soo
2021.09.02 11:57
Korean drugmakers jump into stroke therapy development despite failure risk
Shim Hyun-tai
2021.09.01 18:07
GSK, CureVac’s 2nd-generation Covid-19 vaccine shows promising study results
Shim Hyun-tai
2021.09.01 16:45
Korean firms racing to tap $18 billion gastric acid blocker market
Kim Chan-hyuk
2021.09.01 15:45
SK Biopharmaceuticals' US partner gets nod for sleepiness treatment in Canada
Lee Han-soo
2021.09.01 14:41
처음
이전
이전
이전
191
192
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기